Antimicrobial Exploration Between Counterpart Endosymbiont and Host Plant (Tamarindus indica Linn.)

被引:0
作者
Chigurupati, Sridevi [1 ]
Vijayabalan, Shantini [2 ]
Selvarajan, Kesavanarayanan K. [3 ]
Aldubayan, Maha [4 ]
Alhowail, Ahrnad [4 ]
Mani, Vasudevan [4 ]
Das, Suprava [5 ]
机构
[1] Qassim Univ, Coll Pharm, Dept Med Chem & Pharmacognosy, Buraydah 52571, Saudi Arabia
[2] AIMST Univ, Fac Pharm, Dept Pharmaceut Chem, Bedong 08100, Kedah, Malaysia
[3] Univ Hail, Coll Pharm, Dept Pharmacol & Toxicol, Hail, Saudi Arabia
[4] Qassim Univ, Coll Pharm, Dept Pharmacol & Toxicol, Buraydah, Saudi Arabia
[5] AIMST Univ, Fac Med, Dept Pharmacol, Bedong 08100, Kedah, Malaysia
关键词
Tamarindus Indica; endophyte; phytochemical analysis; antimicrobial; phytoconstituents; rRNA; ANTIBACTERIAL; RESISTANCE; POLYPHENOLS; ANTIOXIDANT; PRODUCTS; EXTRACTS; L;
D O I
10.2174/1389201020666191028105325
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Endophytic bacteria produce various bioactive secondary metabolites, which benefit human health. Tamarindus indica L. is well known for its medicinal value in human health care. Several studies have reported on its biological effects from various parts of T. indica, but only a few studies have been devoted to examining the biological activity of endophytes of T. indica. Objectives: In the present study, an endophyte was isolated from the leaves of T. indica and screened for its antimicrobial potential. Methods: The selected endophyte was identified by 16s rRNA partial genome sequencing and investigated for their antimicrobial potency. The preliminary phytochemical tests were conducted for the affirmation of phytoconstituents in the endophytic crude ethyl acetate extract of T. indica (TIM) and total phenolic content was performed. The antimicrobial potential of TIM was evaluated against human pathogenic ATCC gram-positive and gram-negative bacterial strains. Results: TIM exhibited an appreciable amount of gallic acid equivalent phenolic content (21.6 +/- 0.04 mg GAE/g of crude extract). TIM showed the Minimum Inhibitory Concentration (MIC) at 250 mu g/mL and Minimum Bactericidal Concentration (MBC) at 500 gg/mL among the selected human pathogenic ATCC strains. At MIC of 500 mu g/mL, TIM displayed a significant zone of inhibition against P. aeruginosa and N. gonorrhoeae. Conclusion: The results from our study highlighted for the first time the antimicrobial potential of endophytic bacterial strain Bacillus velezensis in T. indica leaves and it could be further explored as a source of natural antimicrobial agents.
引用
收藏
页码:384 / 389
页数:6
相关论文
共 36 条
  • [1] [Anonymous], 2006, PHYTOCHEMICAL TECHNI
  • [2] A Method for Antibiotic Susceptibility Testing: Applicable and Accurate
    Ataee, Ramezan Ali
    Mehrabi-Tavana, Ali
    Hosseini, Seyed Mohammad Javad
    Moridi, Khadijeh
    Zadegan, Mahdi Ghorbananli
    [J]. JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2012, 5 (01) : 341 - 345
  • [3] Screening of endophytic bacteria isolated from leaves of Sambung Nyawa [Gynura procumbens (Lour.) Merr.] for cytokinin-like compounds
    Bhore, Subhash J.
    Nithya, Ravichantar
    Loh, Chye Ying
    [J]. BIOINFORMATION, 2010, 5 (05) : 191 - 197
  • [4] Antioxidant activity and phenolic compounds of 112 traditional Chinese medicinal plants associated with anticancer
    Cai, YZ
    Luo, Q
    Sun, M
    Corke, H
    [J]. LIFE SCIENCES, 2004, 74 (17) : 2157 - 2184
  • [5] Biologically active endophytic streptomycetes from Nothofagus spp. and other plants in Patagonia
    Castillo, Uvidello F.
    Browne, Lindsey
    Strobel, Gary
    Hess, W. M.
    Ezra, Sigal
    Pacheco, Gladys
    Ezra, David
    [J]. MICROBIAL ECOLOGY, 2007, 53 (01) : 12 - 19
  • [6] Antimicrobial activity of extracts from Tamarindus indica L. leaves
    Cesar Escalona-Arranz, Julio
    Peres-Roses, Renato
    Urdaneta-Laffita, Imilci
    Isabel Camacho-Pozo, Miladis
    Rodriguez-Amado, Jesus
    Licea-Jimenez, Irina
    [J]. PHARMACOGNOSY MAGAZINE, 2010, 6 (23) : 242 - 247
  • [7] Chandrappa M.Subhas., 2010, Intl J Pharm Pharmaceutical Sci, V2, P63
  • [8] Chigurupati S., 2015, J Med Bioeng, V4, P363, DOI [10.12720/jomb.4.5.363-366, DOI 10.12720/JOMB.4.5.363-366]
  • [9] Chigurupati S., 2018, ASIAN J PHARM CLIN R, V11, P361
  • [10] Chigurupati S, 2018, INT J PHARMTECH RES, V11, P198, DOI DOI 10.20902/UPTR.2018.11301